Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Melanoma 63Leukemia, Myeloid, Acute 31Leukemia 25Carcinoma, Renal Cell 23Lymphoma 21Kidney Neoplasms 18Precursor Cell Lymphoblastic Leukemia-Lymphoma 14Neoplasm Metastasis 14Lymphoma, Mantle-Cell 13Myelodysplastic Syndromes 12Lymphoma, Non-Hodgkin 12Lymphoma, Follicular 12Leukemia, Lymphocytic, Chronic, B-Cell 12Neuroblastoma 11Ovarian Neoplasms 10Congenital Abnormalities 10Lymphoma, B-Cell, Marginal Zone 9Breast Neoplasms 9Multiple Myeloma 8Hodgkin Disease 8Carcinoma, Non-Small-Cell Lung 8Stomach Neoplasms 7Recurrence 7Lymphoma, Large B-Cell, Diffuse 7Burkitt Lymphoma 7Lymphoma, Large-Cell, Immunoblastic 6Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6Skin Neoplasms 5Pancreatic Neoplasms 5Myeloproliferative Disorders 5

Interventions

Cyclophosphamide 23Paclitaxel 19Epirubicin 14Doxorubicin 13Carboplatin 13Trastuzumab 12Docetaxel 10Taxes 9Albumin-Bound Paclitaxel 7pembrolizumab 5Radiotherapy 5Fluorouracil 5Filgrastim 5Bevacizumab 5130-nm albumin-bound paclitaxel 5pertuzumab 4Neoadjuvant Therapy 4Cisplatin 4eribulin 3Thiotepa 3Tamoxifen 3Panitumumab 3Melphalan 3Magnetic Resonance Spectroscopy 3Flow Cytometry 3Capecitabine 3Biopsy 3sargramostim 2Specimen Handling 2Peripheral Blood Stem Cell Transplantation 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Inflammatory Breast Neoplasms × aldesleukin × Clear all
NCT00003199 2017-07-12

Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer

Fred Hutchinson Cancer Center

Phase 2 Completed
50 enrolled 11 charts
Breast

Breast Neoplasms, Breast Neoplasms, Male, Inflammatory Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡